| All news about Paradigm Biopharmaceuticals Ltd |
|
|
|
|
|
|
|
Financial Statements
| CA 2023 |
–
–
–
|
| 2023 net result |
-58.5 m
-38.6 m
-37.6 m
|
| Net debt 2023 |
–
–
–
|
| per 2023 |
-8.50x |
| Return 2023 |
– |
|
| capitalization |
485 m
319 m
312 m
|
| Cappy. / CA 2023 |
– |
| Cappy. / CA 2024 |
– |
| Number of Employees |
– |
| floating |
93.5% |
|
| Paradigm Biopharmaceuticals Ltd |
|
Difficult :
a period:
|
|
|
|
TREND TECHNICAL ANALYSIS PARADIGM BIOPHARMACEUTICALS LIMITED
|
Short term |
middle limit |
Long term |
| trends |
rising |
neutral |
neutral |
The evolution of the income statement
|
|
| Average recommendation |
He buys |
| number of analysts |
2 |
| The last closing price |
$1.70 |
| Average target price |
$2.20 |
| Deviation/average of target |
29.4% |
|
